The company have demonstrably advanced this course of a new therapy for ATTR-CM, utilizing the compound. Early patient data indicates promising outcomes for those affected from this severe disease. This emphasis https://attrcm988490.jaiblogs.com/69221237/bridgebio-advances-attr-cm-treatment-using-attruby